| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Circulation, Vol 73, 418-427, Copyright © 1986 by American Heart Association
MJ Davies, AC Thomas, PA Knapman and JR Hangartner
A specific search for intramyocardial platelet aggregates was made in 90
patients who died suddenly of ischemic heart disease. Platelet aggregates
in small intramyocardial vessels were found in 27 (30%). There was a
significant difference (p less than .05) in the incidence of platelet
aggregates in patients with chest pain of recent onset (unstable angina)
before death (16/36, 44.4%) and that in those without it (11/54, 20.4%).
Multifocal microscopic necrosis with involvement of the full thickness of
the ventricular wall, including the subpericardial zone, was significantly
more common (p = less than .005) in the patients with platelet emboli
(55.6% vs 12.7%). With one exception, aggregates were confined to the
segment of myocardium immediately downstream of a major epicardial coronary
artery containing an atheromatous plaque that had undergone fissuring and
on which mural thrombus had developed. The results support the view that
platelet aggregates in the myocardium represent an embolic phenomenon and
are a potential cause of unstable angina. The association of myocardial
necrosis with such emboli could precipitate sudden death from ventricular
fibrillation.
ARTICLES
Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death
This article has been cited by other articles:
![]() |
C. M. Gibson, Y. B. Pride, J. L. Buros, E. Lord, A. Shui, S. A. Murphy, D. S. Pinto, P. J. Zimetbaum, M. S. Sabatine, C. P. Cannon, et al. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol., February 5, 2008; 51(5): 546 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, J.-P. Bassand, C. W. Hamm, D. Ardissino, E. Boersma, A. Budaj, F. Fernandez-Aviles, K. A.A. Fox, D. Hasdai, E. M. Ohman, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology Eur. Heart J., July 1, 2007; 28(13): 1598 - 1660. [Full Text] [PDF] |
||||
![]() |
A. Skyschally, P. Gres, S. Hoffmann, M. Haude, R. Erbel, R. Schulz, and G. Heusch Bidirectional Role of Tumor Necrosis Factor-{alpha} in Coronary Microembolization: Progressive Contractile Dysfunction Versus Delayed Protection Against Infarction Circ. Res., January 5, 2007; 100(1): 140 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. M. Ruggeri, J. N. Orje, R. Habermann, A. B. Federici, and A. J. Reininger Activation-independent platelet adhesion and aggregation under elevated shear stress Blood, September 15, 2006; 108(6): 1903 - 1910. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-Y. Zhang, J.-B. Ge, J.-Z. Chen, J.-H. Zhu, L.-H. Zhang, C.-P. Lau, and H.-F. Tse Mast Cell Contributes to Cardiomyocyte Apoptosis after Coronary Microembolization J. Histochem. Cytochem., May 1, 2006; 54(5): 515 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yamashita, E. Furukoji, K. Marutsuka, K. Hatakeyama, H. Yamamoto, S. Tamura, Y. Ikeda, A. Sumiyoshi, and Y. Asada Increased Vascular Wall Thrombogenicity Combined With Reduced Blood Flow Promotes Occlusive Thrombus Formation in Rabbit Femoral Artery Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2420 - 2424. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Malyar, L. O. Lerman, M. Gossl, P. E. Beighley, and E. L. Ritman Relation of Nonperfused Myocardial Volume and Surface Area to Left Ventricular Performance in Coronary Microembolization Circulation, October 5, 2004; 110(14): 1946 - 1952. [Abstract] [Full Text] [PDF] |
||||
![]() |
C H Lee, P de Feyter, P W Serruys, F Saia, P A Lemos, D Goedhart, P R Soares, V A W M Umans, M Ciccone, and M Cortellaro Beneficial effects of fluvastatin following percutaneous coronary intervention in patients with unstable and stable angina: results from the Lescol intervention prevention study (LIPS) Heart, October 1, 2004; 90(10): 1156 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Heusch and K. R. Sipido Myocardial Hibernation: A Double-Edged Sword Circ. Res., April 30, 2004; 94(8): 1005 - 1007. [Full Text] [PDF] |
||||
![]() |
K. Okamatsu, M. Takano, S. Sakai, F. Ishibashi, R. Uemura, T. Takano, and K. Mizuno Elevated Troponin T Levels and Lesion Characteristics in Non-ST-Elevation Acute Coronary Syndromes Circulation, February 3, 2004; 109(4): 465 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kaul and H. Ito Microvasculature in Acute Myocardial Ischemia: Part II: Evolving Concepts in Pathophysiology, Diagnosis, and Treatment Circulation, January 27, 2004; 109(3): 310 - 315. [Full Text] [PDF] |
||||
![]() |
P O Collinson and P J Stubbs Are troponins confusing? Heart, November 1, 2003; 89(11): 1285 - 1287. [Full Text] [PDF] |
||||
![]() |
D. Ardissino, P. A. Merlini, K. A. Bauer, M. Galvani, F. Ottani, F. Franchi, F. Bertocchi, R. D. Rosenberg, and P. M. Mannucci Coagulation activation and long-term outcome in acute coronary syndromes Blood, October 15, 2003; 102(8): 2731 - 2735. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Baldus, C. Heeschen, T. Meinertz, A. M. Zeiher, J. P. Eiserich, T. Munzel, M. L. Simoons, C. W. Hamm, and on behalf of the CAPTURE Investigators Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes Circulation, September 23, 2003; 108(12): 1440 - 1445. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Falk and L Thuesen Pathology of coronary microembolisation and no reflow Heart, September 1, 2003; 89(9): 983 - 985. [Full Text] [PDF] |
||||
![]() |
G. C. Wong, R. P. Giugliano, and E. M. Antman Use of Low-Molecular-Weight Heparins in the Management of Acute Coronary Artery Syndromes and Percutaneous Coronary Intervention JAMA, January 15, 2003; 289(3): 331 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamamoto, H. Ito, K. Iwakura, S. Kawano, M. Ikushima, T. Masuyama, T. Ogihara, and K. Fujii Two different coronary blood flow velocity patterns in thrombolysis in myocardial infarction flow grade 2 in acute myocardial infarction: Insight into mechanisms of microvascular dysfunction J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1755 - 1760. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Baker Jr Thrombolytic Therapy Clinical and Applied Thrombosis/Hemostasis, October 1, 2002; 8(4): 291 - 314. [PDF] |
||||
![]() |
M. Mirabet, D. Garcia-Dorado, J. Inserte, J. A. Barrabes, R.-M. Lidon, B. Soriano, M. Azevedo, F. Padilla, L. Agullo, M. Ruiz-Meana, et al. Platelets activated by transient coronary occlusion exacerbate ischemia-reperfusion injury in rat hearts Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1134 - H1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Bonz, B. Lengenfelder, J.o. Strotmann, S. Held, O. Turschner, K. Harre, C. Wacker, C. Waller, N. Kochsiek, M. Meesmann, et al. effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial) J. Am. Coll. Cardiol., August 21, 2002; 40(4): 662 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Thielmann, H. Dorge, C. Martin, S. Belosjorow, U. Schwanke, A. van de Sand, I. Konietzka, A. Buchert, A. Kruger, R. Schulz, et al. Myocardial Dysfunction With Coronary Microembolization: Signal Transduction Through a Sequence of Nitric Oxide, Tumor Necrosis Factor-{alpha}, and Sphingosine Circ. Res., April 19, 2002; 90(7): 807 - 813. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Barrabes, D. Garcia-Dorado, M. Mirabet, R.-M. Lidon, B. Soriano, M. Ruiz-Meana, P. Pizcueta, J. Blanco, Y. Puigfel, and J. Soler-Soler Lack of effect of glycoprotein IIb/IIIa blockade on myocardial platelet or polymorphonuclear leukocyte accumulation and on infarct size after transient coronary occlusion in pigs J. Am. Coll. Cardiol., January 2, 2002; 39(1): 157 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hirsh, S. S. Anand, J. L. Halperin, and V. Fuster Guide to Anticoagulant Therapy: Heparin : A Statement for Healthcare Professionals From the American Heart Association Arterioscler. Thromb. Vasc. Biol., July 1, 2001; 21 (7): e9 - e9. [Full Text] [PDF] |
||||
![]() |
J. Hirsh, S. S. Anand, J. L. Halperin, and V. Fuster Guide to Anticoagulant Therapy: Heparin : A Statement for Healthcare Professionals From the American Heart Association Circulation, June 19, 2001; 103(24): 2994 - 3018. [Full Text] [PDF] |
||||
![]() |
C.W. Hamm GP IIb/IIIa receptor antagonists in unstable angina: troponin level-based patient selection Eur. Heart J. Suppl., May 1, 2001; 3(suppl_A): A14 - A20. [Abstract] [PDF] |
||||
![]() |
S.K.S. Lairikyengbam, A.G. Davies, and M.H. Anderson Present treatment options for unstable angina and non-Q-wave myocardial infarction QJM, January 1, 2001; 94(1): 5 - 11. [Full Text] [PDF] |
||||
![]() |
K. M. Akkerhuis, K.-L. Neuhaus, R. G. Wilcox, A. Vahanian, J.-L. Boland, J. Hoffmann, T. Baardman, G. Nehmiz, U. Roth, A. P. J. Klootwijk, et al. Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation A phase II study Eur. Heart J., December 2, 2000; 21(24): 2042 - 2055. [Abstract] [PDF] |
||||
![]() |
D. Cox, R. Smith, M. Quinn, P. Theroux, P. Crean, and D. J. Fitzgerald Evidence of platelet activation during treatment with a GPIIb/IIIa antagonist in patients presenting with acute coronary syndromes J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1514 - 1519. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A Barrabes, D. Garcia-Dorado, B. Soriano, J. Solares, Y. Puigfel, L. Trobo, A. Garcia-Lafuente, and J. Soler-Soler Dynamic intracoronary thrombosis does not cause significant downstream platelet embolization Cardiovasc Res, August 1, 2000; 47(2): 265 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Hamm and E. Braunwald A Classification of Unstable Angina Revisited Circulation, July 4, 2000; 102(1): 118 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Heeschen, B.U. Goldmann, W. Terres, and C.W. Hamm Cardiovascular risk and therapeutic benefit of coronary interventions for patients with unstable angina according to the troponin T status Eur. Heart J., July 2, 2000; 21(14): 1159 - 1166. [Abstract] [PDF] |
||||
![]() |
R. Erbel and G. Heusch Coronary microembolization J. Am. Coll. Cardiol., July 1, 2000; 36(1): 22 - 24. [Full Text] [PDF] |
||||
![]() |
C. Heeschen, C. W. Hamm, J. Bruemmer, M. L. Simoons, and for the CAPTURE Investigators Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1535 - 1542. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J Davies CORONARY DISEASE: The pathophysiology of acute coronary syndromes Heart, March 1, 2000; 83(3): 361 - 366. [Full Text] |
||||
![]() |
E. J. Topol and J. S. Yadav Recognition of the Importance of Embolization in Atherosclerotic Vascular Disease Circulation, February 8, 2000; 101(5): 570 - 580. [Full Text] [PDF] |
||||
![]() |
X.-Q. Zhao, P. Theroux, S. M. Snapinn, and F. L. Sax Intracoronary Thrombus and Platelet Glycoprotein IIb/IIIa Receptor Blockade With Tirofiban in Unstable Angina or Non-Q-Wave Myocardial Infarction : Angiographic Results From the PRISM-PLUS Trial (Platelet Receptor Inhibition for Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms) Circulation, October 12, 1999; 100(15): 1609 - 1615. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Heeschen, M. J. van den Brand, C. W. Hamm, and M. L. Simoons Angiographic Findings in Patients With Refractory Unstable Angina According to Troponin T Status Circulation, October 5, 1999; 100(14): 1509 - 1514. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Wang and L.-J. Cheng Effect of Strenuous, Acute Exercise on {alpha}2-Adrenergic Agonist–Potentiated Platelet Activation Arterioscler. Thromb. Vasc. Biol., June 1, 1999; 19(6): 1559 - 1565. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Hamm, C. Heeschen, B. Goldmann, A. Vahanian, J. Adgey, C. M. Miguel, W. Rutsch, J. Berger, J. Kootstra, M. L. Simoons, et al. Benefit of Abciximab in Patients with Refractory Unstable Angina in Relation to Serum Troponin T Levels N. Engl. J. Med., May 27, 1999; 340(21): 1623 - 1629. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Mansaray, P.R Belcher, I Vergroesen, Z.M Wright, J.W Hynd, A.J Drake-Holland, and M.I.M Noble Downstream resistance effects of intracoronary thrombosis in the stenosed canine coronary artery Cardiovasc Res, April 1, 1999; 42(1): 193 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Mickelson, M. N. Ali, N. S. Kleiman, N. M. Lakkis, T. W. Chow, B. J. Hughes, and C. W. Smith Chimeric 7e3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing coronary angioplasty J. Am. Coll. Cardiol., January 1, 1999; 33(1): 97 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
Management of unstable angina DTB, May 1, 1998; 36(5): 36 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Baker JR Thrombosis and Hemostasis in Cardiology: Review of Pathophysiology and Clinical Practice (Part I) Clinical and Applied Thrombosis/Hemostasis, January 1, 1998; 4(1): 51 - 75. [Abstract] [PDF] |
||||
![]() |
C. W. Hamm, B. U. Goldmann, C. Heeschen, G. Kreymann, J. Berger, and T. Meinertz Emergency Room Triage of Patients with Acute Chest Pain by Means of Rapid Testing for Cardiac Troponin T or Troponin I N. Engl. J. Med., December 4, 1997; 337(23): 1648 - 1653. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mehta, J. Curwin, J. A. Gomes, and V. Fuster Sudden Death in Coronary Artery Disease : Acute Ischemia Versus Myocardial Substrate Circulation, November 4, 1997; 96(9): 3215 - 3223. [Full Text] |
||||
![]() |
J.-S. Wang, C. J. Jen, H.-L. Lee, and H.-i. Chen Effects of Short-term Exercise on Female Platelet Function During Different Phases of the Menstrual Cycle Arterioscler. Thromb. Vasc. Biol., September 1, 1997; 17(9): 1682 - 1686. [Abstract] [Full Text] |
||||
![]() |
M. Galvani, F. Ottani, D. Ferrini, J. H. Ladenson, A. Destro, D. Baccos, F. Rusticali, and A. S. Jaffe Prognostic Influence of Elevated Values of Cardiac Troponin I in Patients With Unstable Angina Circulation, April 15, 1997; 95(8): 2053 - 2059. [Abstract] [Full Text] |
||||
![]() |
Y.-H. Chen, Y.-L. Chen, S.-J. Lin, C.-Y. Chou, G.-Y. Mar, M.-S. Chang, and S.-P. Wang Electron Microscopic Studies of Phenotypic Modulation of Smooth Muscle Cells in Coronary Arteries of Patients With Unstable Angina Pectoris and Postangioplasty Restenosis Circulation, March 4, 1997; 95(5): 1169 - 1175. [Abstract] [Full Text] |
||||
![]() |
M. D. Ozner, Y. S. Ahn, L. L. Horstman, W. Jy, L. Kolodny, and R. J. Myerberg Chronic Platelet Activation and Acute Coronary Syndromes in 13 Middle-Aged Patients Clinical and Applied Thrombosis/Hemostasis, January 1, 1997; 3(1): 46 - 53. [Abstract] [PDF] |
||||
![]() |
E. M. Antman, M. J. Tanasijevic, B. Thompson, M. Schactman, C. H. McCabe, C. P. Cannon, G. A. Fischer, A. Y. Fung, C. Thompson, D. Wybenga, et al. Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes N. Engl. J. Med., October 31, 1996; 335(18): 1342 - 1349. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Davies Stability and Instability: Two Faces of Coronary Atherosclerosis: The Paul Dudley White Lecture 1995 Circulation, October 15, 1996; 94(8): 2013 - 2020. [Full Text] |
||||
![]() |
P. Stubbs, P. Collinson, D. Moseley, T. Greenwood, and M. Noble Prospective study of the role of cardiac troponin T in patients admitted with unstable angina BMJ, August 3, 1996; 313(7052): 262 - 264. [Abstract] [Full Text] |
||||
![]() |
P. Savi, E. Heilmann, P. Nurden, M.-C. Laplace, C. Bihour, G. Kieffer, A. T. Nurden, and J.-M. Herbert Clopidogrel: An Antithrombotic Drug Acting on the ADP-dependent Activation Pathway of Human Platelets Clinical and Applied Thrombosis/Hemostasis, January 1, 1996; 2(1): 35 - 42. [Abstract] [PDF] |
||||
![]() |
J.-s. Wang, C. J. Jen, and H.-i. Chen Effects of Exercise Training and Deconditioning on Platelet Function in Men Arterioscler. Thromb. Vasc. Biol., October 1, 1995; 15(10): 1668 - 1674. [Abstract] [Full Text] |
||||
![]() |
H. Ikeda, Y. Takajo, K. Ichiki, T. Ueno, S. Maki, T. Noda, K. Sugi, and T. Imaizumi Increased Soluble Form of P-Selectin in Patients With Unstable Angina Circulation, October 1, 1995; 92(7): 1693 - 1696. [Abstract] [Full Text] |
||||
![]() |
J. A. Bittl, J. Strony, J. A. Brinker, W. H. Ahmed, C. R. Meckel, B. R. Chaitman, J. Maraganore, E. Deutsch, B. Adelman, and The Hirulog Angioplasty Study Investigators Treatment with Bivalirudin (Hirulog) as Compared with Heparin during Coronary Angioplasty for Unstable or Postinfarction Angina N. Engl. J. Med., September 21, 1995; 333(12): 764 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Johnson and T. Ports Unstable Angina Pectoris: An Interventional Approach to Management J Intensive Care Med, July 1, 1988; 3(4): 202 - 214. [Abstract] [PDF] |
||||
![]() |
M. Thielmann, H. Dorge, C. Martin, S. Belosjorow, U. Schwanke, A. van de Sand, I. Konietzka, A. Buchert, A. Kruger, R. Schulz, et al. Myocardial Dysfunction With Coronary Microembolization: Signal Transduction Through a Sequence of Nitric Oxide, Tumor Necrosis Factor-{alpha}, and Sphingosine Circ. Res., April 19, 2002; 90(7): 807 - 813. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1986 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |